Universal Biosensors Inc (UBI)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Universal Biosensors Inc (UBI) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011972
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Universal Biosensors Inc (UBI) is a medical diagnostic company. The company researches, develops and manufactures in vitro diagnostic test devices that are used for professional and consumer point-of-care. The company is working with Siemens Healthcare to develop a range of products for the point-of-care coagulation market and will manufacture test strips for these products. UBI’s major focus areas include coagulation testing, blood glucose testing and other electromechanical cell based tests. Its in-vitro diagnostic test devices are based on electrochemical cell technology platform. The company manages its research and development, and manufacturing operations through its subsidiary, Universal Biosensors Pty Ltd (UBS) in Melbourne. UBI is headquartered in Melbourne, Victoria, Australia.

Universal Biosensors Inc (UBI) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Universal Biosensors Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Universal Biosensors Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Universal Biosensors Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Universal Biosensors Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Universal Biosensors Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Universal Biosensors Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
Universal Biosensors to Acquire Hemostasis Reference Lab Business from LifeLabs 10
Partnerships 11
Universal Biosensors Enters Into Licensing Agreement With SpeeDx 11
Siemens Healthcare Diagnostics Amends its Co-Development Agreement with Universal Biosensors 12
Equity Offering 13
Universal Biosensors Completes Private Placement Of Shares For US$12 Million 13
Universal Biosensors Inc – Key Competitors 14
Universal Biosensors Inc – Key Employees 15
Universal Biosensors Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
Oct 24, 2017: Universal Biosensors releases Q3 2017 results – continued revenue growth strengthens net cash position 17
Apr 27, 2017: Universal Biosensors reports strong growth in revenue and profit in Q1 2017 18
Feb 27, 2017: Universal Biosensors announces FY2016 unaudited results showing strong revenue growth and positive operating cash flow 19
Aug 20, 2016: Universal Biosensors reports growing revenues in 3Q16 with positive cash flow 20
Jul 21, 2016: Universal Biosensors: Revenue up 41% on pcp as Quarterly Service Fees continue to grow 21
Jul 21, 2016: Universal Biosensors Announced its financial results for the first half of 2016 22
Apr 21, 2016: Universal Biosensors Reports Q1 2016 Results 23
Corporate Communications 24
Aug 07, 2017: Rick Legleiter Appointed Chief Executive Officer, Chairman Succession and Board Renewal Process 24
Jun 30, 2016: UBI appoints Craig Coleman as Non-Executive Director 26
Mar 02, 2016: Universal Biosensors Appoints David Hoey as Non-Executive Director 27
Feb 19, 2016: Universal Biosensors Announces Retirement of CEO Paul Wright 28
Other Significant Developments 29
Apr 01, 2016: Universal Biosensors – Update 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Universal Biosensors Inc, Medical Equipment, Key Facts, 2016 2
Universal Biosensors Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Universal Biosensors Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Universal Biosensors Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Universal Biosensors Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Universal Biosensors Inc, Deals By Market, 2011 to YTD 2017 8
Universal Biosensors Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Universal Biosensors to Acquire Hemostasis Reference Lab Business from LifeLabs 10
Universal Biosensors Enters Into Licensing Agreement With SpeeDx 11
Siemens Healthcare Diagnostics Amends its Co-Development Agreement with Universal Biosensors 12
Universal Biosensors Completes Private Placement Of Shares For US$12 Million 13
Universal Biosensors Inc, Key Competitors 14
Universal Biosensors Inc, Key Employees 15
Universal Biosensors Inc, Subsidiaries 16

★海外企業調査レポート[Universal Biosensors Inc (UBI)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Covalon Technologies Ltd (COV)-医療機器分野:企業M&A・提携分析
    Summary Covalon Technologies Ltd (Covalon) is a researcher, developer and commercialization of medical devices and healthcare technologies. The company offers advanced wound solutions, infection prevention products and perioperative care products. Covalon offers wound care products such as collagen …
  • General Re Corporation:企業の戦略・SWOT・財務情報
    General Re Corporation - Strategy, SWOT and Corporate Finance Report Summary General Re Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • PledPharma AB (PLED):企業の財務・戦略的SWOT分析
    Summary PledPharma AB (PledPharma) is a pharmaceutical company that discovers, manufactures, and develops drugs that protect the body against oxidative stress. The company discovers and develops Aladote and PledOx drugs. PledOX drug is used to prevent chemotherapy-induced side effects for colorectal …
  • Orange SA (ORA):企業の財務・戦略的SWOT分析
    Orange SA (ORA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Aeroflot Oao
    Aeroflot Oao - Strategy, SWOT and Corporate Finance Report Summary Aeroflot Oao - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Northrop Grumman Technical Services Inc.:企業の戦略・SWOT・財務分析
    Northrop Grumman Technical Services Inc. - Strategy, SWOT and Corporate Finance Report Summary Northrop Grumman Technical Services Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Trustpower Limited:電力:M&Aディール及び事業提携情報
    Summary TrustPower Limited (Trustpower), a subsidiary of Infratil Ltd, is a generator and retailer of electricity and supplies gas and telecommunication services. The company produces electricity from wind, hydro, geothermal and diesel sources. It owns and operates various power projects across New …
  • NuScale Power LLC:企業の戦略的SWOT分析
    NuScale Power LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Arch Capital Group Ltd.:企業の戦略・SWOT・財務情報
    Arch Capital Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Arch Capital Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Cancom SE (COK):企業の財務・戦略的SWOT分析
    Cancom SE (COK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Western Refining, Inc. (WNR)-石油・ガス分野:企業M&A・提携分析
    Summary Western Refining, Inc. (Western Refining) is a downstream oil and gas company that refines crude and markets its derivatives. The company’s product portfolio comprises gasoline, diesel fuel, jet fuel, and asphalt. The company operates refineries in El Paso, Texas; Gallup, Mexico; and St. Pau …
  • Farmer Bros. Co.:企業の戦略・SWOT・財務情報
    Farmer Bros. Co. - Strategy, SWOT and Corporate Finance Report Summary Farmer Bros. Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Abivax SA (ABVX):企業の財務・戦略的SWOT分析
    Summary Abivax SA (Abivax) operates as a biotechnology company. It develops and commercializes anti-viral therapies and therapeutic vaccines for the treatment of infectious and viral diseases. The company’s pipeline products include ABX464, ABX544 and ABX196. Its ABX464 is an oral small molecule to …
  • Elekta AB (EKTA B):医療機器:M&Aディール及び事業提携情報
    Summary Elekta AB (Elekta) is a medical technology company that offers image guided and stereotactic clinical solutions, comprehensive information systems and services for the management of brain disorders and improved cancer care. Its major products include Gamma knife and Extend system; stereotact …
  • Fortune Brands Home & Security Inc:企業の戦略・SWOT・財務分析
    Fortune Brands Home & Security Inc - Strategy, SWOT and Corporate Finance Report Summary Fortune Brands Home & Security Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Westrock Company:企業の戦略・SWOT・財務情報
    Westrock Company - Strategy, SWOT and Corporate Finance Report Summary Westrock Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Macrogen Inc (038290):企業の財務・戦略的SWOT分析
    Macrogen Inc (038290) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Braeburn Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Braeburn Inc (Braeburn), formerly Braeburn Pharmaceuticals Inc (Braeburn), is a biopharmaceutical company that develops medicines for the treatment of opioid addiction. The company’s lead product candidate CAM2038 is a weekly and monthly subcutaneous injection depot formulation of buprenorph …
  • CCP Technologies Ltd (CT1)-医療機器分野:企業M&A・提携分析
    Summary CCP Technologies Ltd (CCP), formerly Agenix Ltd is a technology company that offers business-to-business hardware and software solutions. The company develops Internet of Things’ solutions for management of computers, smart phones, sensors and diverse equipment. It offers business hardware a …
  • Standard Chem & Pharm Co Ltd:企業の戦略・SWOT・財務分析
    Standard Chem & Pharm Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Standard Chem & Pharm Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆